Annual Shareholders Equity
$39.14 B
+$2.11 B+5.69%
31 December 2023
Summary:
AstraZeneca annual stockholders equity is currently $39.14 billion, with the most recent change of +$2.11 billion (+5.69%) on 31 December 2023. During the last 3 years, it has risen by +$23.52 billion (+150.56%). AZN annual shareholders equity is now -0.32% below its all-time high of $39.27 billion, reached on 31 December 2021.AZN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$40.72 B
+$1.21 B+3.05%
30 September 2024
Summary:
AstraZeneca quarterly stockholders equity is currently $40.72 billion, with the most recent change of +$1.21 billion (+3.05%) on 30 September 2024. Over the past year, it has increased by +$3.52 billion (+9.47%). AZN quarterly shareholders equity is now at all-time high.AZN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.7% | +9.5% |
| 3 y3 years | +150.6% | +2.5% |
| 5 y5 years | +213.9% | +234.8% |
AZN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.3% | +150.6% | at high | +15.9% |
| 5 y | 5 years | -0.3% | +213.9% | at high | +277.8% |
| alltime | all time | -0.3% | >+9999.0% | at high | +1736.4% |
AstraZeneca Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.72 B(+3.1%) |
| June 2024 | - | $39.51 B(+5.5%) |
| Mar 2024 | - | $37.45 B(-4.3%) |
| Dec 2023 | $39.14 B(+5.7%) | $39.14 B(+5.2%) |
| Sept 2023 | - | $37.20 B(-0.5%) |
| June 2023 | - | $37.39 B(+4.5%) |
| Mar 2023 | - | $35.79 B(-3.4%) |
| Dec 2022 | $37.04 B(-5.7%) | $37.04 B(+5.4%) |
| Sept 2022 | - | $35.13 B(-2.2%) |
| June 2022 | - | $35.93 B(-1.1%) |
| Mar 2022 | - | $36.34 B(-7.5%) |
| Dec 2021 | $39.27 B(+151.4%) | $39.27 B(-1.2%) |
| Sept 2021 | - | $39.74 B(+153.5%) |
| June 2021 | - | $15.68 B(+8.6%) |
| Mar 2021 | - | $14.43 B(-7.6%) |
| Dec 2020 | $15.62 B(+19.0%) | $15.62 B(+28.1%) |
| Sept 2020 | - | $12.20 B(-0.3%) |
| June 2020 | - | $12.24 B(+13.5%) |
| Mar 2020 | - | $10.78 B(-17.9%) |
| Dec 2019 | $13.13 B(+5.3%) | $13.13 B(+7.9%) |
| Sept 2019 | - | $12.16 B(-10.2%) |
| June 2019 | - | $13.55 B(+29.2%) |
| Mar 2019 | - | $10.48 B(-15.9%) |
| Dec 2018 | $12.47 B(-16.7%) | $12.47 B(+4.5%) |
| Sept 2018 | - | $11.94 B(-5.6%) |
| June 2018 | - | $12.64 B(-2.1%) |
| Mar 2018 | - | $12.91 B(-13.7%) |
| Dec 2017 | $14.96 B(+0.7%) | $14.96 B(+9.0%) |
| Sept 2017 | - | $13.72 B(+0.5%) |
| June 2017 | - | $13.65 B(+5.1%) |
| Mar 2017 | - | $12.99 B(-12.6%) |
| Dec 2016 | $14.85 B(-19.7%) | $14.85 B(+13.6%) |
| Sept 2016 | - | $13.07 B(-3.4%) |
| June 2016 | - | $13.53 B(-8.2%) |
| Mar 2016 | - | $14.74 B(-20.3%) |
| Dec 2015 | $18.49 B(-5.8%) | $18.49 B(+6.6%) |
| Sept 2015 | - | $17.35 B(-5.1%) |
| June 2015 | - | $18.28 B(+7.9%) |
| Mar 2015 | - | $16.94 B(-13.7%) |
| Dec 2014 | $19.63 B(-15.5%) | $19.63 B(-4.0%) |
| Sept 2014 | - | $20.45 B(-7.2%) |
| June 2014 | - | $22.03 B(+2.7%) |
| Mar 2014 | - | $21.45 B(-7.6%) |
| Dec 2013 | $23.22 B(-2.1%) | $23.22 B(-0.1%) |
| Sept 2013 | - | $23.25 B(+0.1%) |
| June 2013 | - | $23.22 B(+4.1%) |
| Mar 2013 | - | $22.29 B(-6.1%) |
| Dec 2012 | $23.73 B(+2.1%) | $23.73 B(+7.7%) |
| Sept 2012 | - | $22.04 B(+0.1%) |
| June 2012 | - | $22.03 B(+2.4%) |
| Mar 2012 | - | $21.52 B(-7.4%) |
| Dec 2011 | $23.24 B(+0.1%) | $23.24 B(-2.9%) |
| Sept 2011 | - | $23.93 B(+1.4%) |
| June 2011 | - | $23.61 B(+5.6%) |
| Mar 2011 | - | $22.35 B(-3.7%) |
| Dec 2010 | $23.21 B | $23.21 B(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $22.13 B(+0.2%) |
| June 2010 | - | $22.09 B(+6.6%) |
| Mar 2010 | - | $20.73 B(+0.3%) |
| Dec 2009 | $20.66 B(+29.8%) | $20.66 B(+6.5%) |
| Sept 2009 | - | $19.39 B(+9.0%) |
| June 2009 | - | $17.80 B(+15.7%) |
| Mar 2009 | - | $15.38 B(-3.3%) |
| Dec 2008 | $15.91 B(+7.7%) | $15.91 B(-1.2%) |
| Sept 2008 | - | $16.11 B(+0.8%) |
| June 2008 | - | $15.97 B(+8.5%) |
| Mar 2008 | - | $14.72 B(-0.4%) |
| Dec 2007 | $14.78 B(-3.4%) | $14.78 B(+1.1%) |
| Sept 2007 | - | $14.61 B(-1.6%) |
| June 2007 | - | $14.85 B(+6.8%) |
| Mar 2007 | - | $13.91 B(-9.1%) |
| Dec 2006 | $15.30 B(+12.6%) | $15.30 B(+4.2%) |
| Sept 2006 | - | $14.68 B(-1.5%) |
| June 2006 | - | $14.91 B(-2.6%) |
| Mar 2006 | - | $15.30 B(+12.6%) |
| Dec 2005 | $13.60 B(-5.6%) | $13.60 B(+2.4%) |
| Sept 2005 | - | $13.28 B(-1.5%) |
| June 2005 | - | $13.48 B(-0.9%) |
| Mar 2005 | - | $13.60 B(-5.6%) |
| Dec 2004 | $14.40 B(+9.3%) | $14.40 B(+8.0%) |
| Sept 2004 | - | $13.33 B(+4.9%) |
| June 2004 | - | $12.71 B(+3.1%) |
| Mar 2004 | - | $12.32 B(-6.5%) |
| Dec 2003 | $13.18 B(+18.0%) | $13.18 B(-2.9%) |
| Sept 2003 | - | $13.56 B(+6.5%) |
| June 2003 | - | $12.73 B(+4.6%) |
| Mar 2003 | - | $12.17 B(+9.0%) |
| Dec 2002 | $11.17 B(+16.5%) | $11.17 B(-3.3%) |
| Sept 2002 | - | $11.55 B(+4.5%) |
| June 2002 | - | $11.06 B(+5.4%) |
| Mar 2002 | - | $10.49 B(+9.5%) |
| Dec 2001 | $9.59 B(+0.6%) | $9.59 B(-4.1%) |
| Sept 2001 | - | $9.99 B(+5.2%) |
| June 2001 | - | $9.50 B(-0.3%) |
| Mar 2001 | - | $9.53 B(+0.0%) |
| Dec 2000 | $9.53 B(-7.5%) | $9.53 B(-11.8%) |
| Sept 2000 | - | $10.81 B(+1.6%) |
| June 2000 | - | $10.64 B(+11.6%) |
| Mar 2000 | - | $9.53 B(-7.5%) |
| Dec 1999 | $10.30 B(-5.7%) | $10.30 B(-13.3%) |
| Sept 1999 | - | $11.89 B(+6.7%) |
| June 1999 | - | $11.14 B(+2.0%) |
| Dec 1998 | $10.93 B(+206.1%) | $10.93 B(+168.9%) |
| June 1998 | - | $4.06 B(+13.8%) |
| Dec 1997 | $3.57 B(+2.5%) | $3.57 B(+2.5%) |
| Dec 1996 | $3.48 B(+21.1%) | $3.48 B(+21.1%) |
| Dec 1995 | $2.88 B(+9.2%) | $2.88 B(-2.6%) |
| June 1995 | - | $2.95 B(+12.0%) |
| Dec 1994 | $2.63 B(+18.8%) | $2.63 B(+18.8%) |
| Dec 1993 | $2.22 B(+2558.1%) | $2.22 B |
| Dec 1992 | $83.42 M(-89.3%) | - |
| Dec 1991 | $782.16 M(+37.0%) | - |
| Dec 1990 | $570.97 M | - |
FAQ
- What is AstraZeneca annual stockholders equity?
- What is the all time high annual shareholders equity for AstraZeneca?
- What is AstraZeneca annual shareholders equity year-on-year change?
- What is AstraZeneca quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AstraZeneca?
- What is AstraZeneca quarterly shareholders equity year-on-year change?
What is AstraZeneca annual stockholders equity?
The current annual shareholders equity of AZN is $39.14 B
What is the all time high annual shareholders equity for AstraZeneca?
AstraZeneca all-time high annual stockholders equity is $39.27 B
What is AstraZeneca annual shareholders equity year-on-year change?
Over the past year, AZN annual stockholders equity has changed by +$2.11 B (+5.69%)
What is AstraZeneca quarterly stockholders equity?
The current quarterly shareholders equity of AZN is $40.72 B
What is the all time high quarterly shareholders equity for AstraZeneca?
AstraZeneca all-time high quarterly stockholders equity is $40.72 B
What is AstraZeneca quarterly shareholders equity year-on-year change?
Over the past year, AZN quarterly stockholders equity has changed by +$3.52 B (+9.47%)